这是一篇来自已证抗体库的有关
人类 CCN1的综述,是根据13篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CCN1 抗体。
CCN1 同义词: CYR61; GIG1; IGFBP10
圣克鲁斯生物技术
小鼠 单克隆(A-10) | | 圣克鲁斯生物技术 CCN1抗体(Santa Cruz, sc-374129)被用于被用于免疫印迹在人类样本上 (图 s3b). Int J Mol Sci (2021) ncbi |
小鼠 单克隆(A-10) | | 圣克鲁斯生物技术 CCN1抗体(SantaCruz, SC-374129)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3a). EMBO Mol Med (2018) ncbi |
小鼠 单克隆 | | 圣克鲁斯生物技术 CCN1抗体(Santa Cruz, A-10)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4a). Invest Ophthalmol Vis Sci (2018) ncbi |
小鼠 单克隆(A-10) | | 圣克鲁斯生物技术 CCN1抗体(Santa Cruz, A-10)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4a). Invest Ophthalmol Vis Sci (2018) ncbi |
小鼠 单克隆(A-10) | | 圣克鲁斯生物技术 CCN1抗体(Santa Cruz Biotechnology, sc-374129)被用于被用于免疫印迹在人类样本上 (图 5b). Oncogene (2017) ncbi |
小鼠 单克隆(H-2) | | 圣克鲁斯生物技术 CCN1抗体(SantaCruz, sc271217)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4b). Oncotarget (2016) ncbi |
小鼠 单克隆(A-10) | | 圣克鲁斯生物技术 CCN1抗体(Santa-Cruz, sc-374129)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 S4d). Nat Commun (2015) ncbi |
Novus Biologicals
domestic rabbit 多克隆 | - 抑制或激活实验; 人类; 1-10 ug/ml; 图 5d
- 免疫印迹; 人类; 图 5s1a
| Novus Biologicals CCN1抗体(NOVUS, NB100-356)被用于被用于抑制或激活实验在人类样本上浓度为1-10 ug/ml (图 5d) 和 被用于免疫印迹在人类样本上 (图 5s1a). elife (2020) ncbi |
domestic rabbit 多克隆 | - 免疫组化-石蜡切片; 人类; 5 ug/ml; 图 6a, 6b, 6d
| Novus Biologicals CCN1抗体(Novus, NB100-356R)被用于被用于免疫组化-石蜡切片在人类样本上浓度为5 ug/ml (图 6a, 6b, 6d). Front Oncol (2019) ncbi |
domestic rabbit 多克隆 | - 抑制或激活实验; 人类; 1:1000; 图 5s1a
| Novus Biologicals CCN1抗体(Novus, NB100-356)被用于被用于抑制或激活实验在人类样本上浓度为1:1000 (图 5s1a). elife (2019) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D4H5D) | | 赛信通(上海)生物试剂有限公司 CCN1抗体(CST, 14479)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 6c). Mol Oncol (2021) ncbi |
domestic rabbit 单克隆(D4H5D) | | 赛信通(上海)生物试剂有限公司 CCN1抗体(Cell Signaling Technology, 14479)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2h). Cell Death Dis (2021) ncbi |
domestic rabbit 单克隆(D4H5D) | | 赛信通(上海)生物试剂有限公司 CCN1抗体(Cell Signalin, 14479)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 6h). Oncogene (2021) ncbi |
domestic rabbit 单克隆(D4H5D) | | 赛信通(上海)生物试剂有限公司 CCN1抗体(Cell Signaling, D4H5D)被用于被用于流式细胞仪在人类样本上 (图 s9a). Nat Methods (2016) ncbi |
Ryu H, Nam K, Kim H, Song J, Hwang S, Kim J,
et al. Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor. Int J Mol Sci. 2021;22:
pubmed 出版商
Shields C, Potlapalli S, Cuya Smith S, Chappell S, Chen D, Martinez D,
et al. Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target. Mol Oncol. 2021;:
pubmed 出版商
Zhang H, Gui T, Liu R, Tong K, Wu C, Li Z,
et al. Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1. Cell Death Dis. 2021;12:121
pubmed 出版商
Zarei M, Giannikou K, Du H, Liu H, Duarte M, Johnson S,
et al. MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61. Oncogene. 2021;40:112-126
pubmed 出版商
Mugahid D, Kalocsay M, Liu X, Gruver J, Peshkin L, Kirschner M. YAP regulates cell size and growth dynamics via non-cell autonomous mediators. elife. 2020;9:
pubmed 出版商
Hellinger J, Hüchel S, Goetz L, Bauerschmitz G, Emons G, Gründker C. Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion. Front Oncol. 2019;9:1074
pubmed 出版商
Park M, Kim A, Manandhar S, Oh S, Jang G, Kang L,
et al. CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity. elife. 2019;8:
pubmed 出版商
Greenhough A, Bagley C, Heesom K, Gurevich D, Gay D, Bond M,
et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10:
pubmed 出版商
Ho L, Skiba N, Ullmer C, Rao P. Lysophosphatidic Acid Induces ECM Production via Activation of the Mechanosensitive YAP/TAZ Transcriptional Pathway in Trabecular Meshwork Cells. Invest Ophthalmol Vis Sci. 2018;59:1969-1984
pubmed 出版商
Zhou Y, Huang T, Zhang J, Wong C, Zhang B, Dong Y,
et al. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Oncogene. 2017;36:6518-6530
pubmed 出版商
Gvozdenović A, Boro A, Meier D, Bode Lesniewska B, Born W, Muff R,
et al. Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model. Oncotarget. 2016;7:55141-55154
pubmed 出版商
Thomsen E, Mich J, Yao Z, Hodge R, Doyle A, Jang S,
et al. Fixed single-cell transcriptomic characterization of human radial glial diversity. Nat Methods. 2016;13:87-93
pubmed 出版商
Lazorthes S, Vallot C, Briois S, Aguirrebengoa M, Thuret J, St Laurent G,
et al. A vlincRNA participates in senescence maintenance by relieving H2AZ-mediated repression at the INK4 locus. Nat Commun. 2015;6:5971
pubmed 出版商